Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New injection aims to tame stubborn cholesterol

NCT ID NCT06471218

Summary

This study tested whether a new injectable drug called SHR-1918 could help lower cholesterol in people whose levels were not well controlled. Forty-four adults with high cholesterol received either the drug or a placebo injection to see if it safely reduced their 'bad' LDL cholesterol and triglycerides over six months. The goal was to find a new treatment option for managing this common heart disease risk factor.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Meizhou People's Hospital

    Meizhou, Guangdong, 514031, China

Conditions

Explore the condition pages connected to this study.